You are here
Morpholino Publication Database
This database contains citations and abstracts for research using Morpholino oligos, as well as some review articles incorporating Morpholino data. You can search the content using the filter boxes below.
There are 12351 scientific papers returned from the database with the search filters currently being used below.
There are 12351 scientific papers returned from the database with the search filters currently being used below.
P.131 Building a FORCETM platform-based DMD franchise for the treatment of individuals with mutations amenable to exon skipping
Citation:
Neuromuscul Disord. 2022;32(Suppl 1):S101-S102. doi:10.1016/j.nmd.2022.07.247 Epub:
Not Epub Abstract:
Current treatments for Duchenne muscular dystrophy (DMD) use phosphorodiamidate morpholino oligomer (PMO) to induce exon... Delivery Method:
Fab-linked Organism or Cell Type:
cell culture: patient-derived mytubes, mice, non-human primates Citation Extract: Desjardins C, Venkatesan R, O'Donnell E, Hall J, Russo R, Spring S, Tang K, Davis J, Weeden T, Zanotti S, Beskrovnaya O. P.131 Building a FORCETM platform-based DMD franchise for the treatment of individuals with mutations amenable to exon skipping. Neuromuscul Disord. 2022;32(Suppl 1):S101-S102. doi:10.1016/j.nmd.2022.07.247. |
P.132 Casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: Interim results from the Phase 3 ESSENCE trial
Citation:
Neuromuscul Disord. 2022;32(Suppl 1):S102. doi:10.1016/j.nmd.2022.07.248 Epub:
Not Epub Abstract:
Casimersen is FDA approved for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed DMD gene... Delivery Method:
i.v. infusion Organism or Cell Type:
human Citation Extract: Iannaccone S, Phan H, Straub V, Muntoni F, Wolf D, Malhotra J, Chu R, Darton E, Mercuri E. P.132 Casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: Interim results from the Phase 3 ESSENCE trial. Neuromuscul Disord. 2022;32(Suppl 1):S102. doi:10.1016/j.nmd.2022.07.248. |
P.134 Real-world outcomes of exon skipping therapy use in patients with Duchenne muscular dystrophy: Experience at a single, large tertiary care center
Citation:
Neuromuscul Disord. 2022;32(Suppl 1):S102. doi:10.1016/j.nmd.2022.07.250 Epub:
Not Epub Abstract:
To assess outcomes among patients with Duchenne muscular dystrophy (DMD) receiving exon skipping therapy in real-world practice... Delivery Method:
i.v. infusion Organism or Cell Type:
human Citation Extract: Yaworski A, Duong T, Low J, Gee R, Watson K, Buu M, Kaufman B, Klotz J, Day J, Guzman J, Tesi Rocha C. P.134 Real-world outcomes of exon skipping therapy use in patients with Duchenne muscular dystrophy: Experience at a single, large tertiary care center. Neuromuscul Disord. 2022;32(Suppl 1):S102. doi:10.1016/j.nmd.2022.07.250. |
O.14 EEV-Conjugated PMO results in nuclear foci reduction and aberrant splicing correction in myotonic dystrophy cell and animal models
Citation:
Neuromuscul Disord. 2022;32(Suppl 1):S96. doi:/10.1016/j.nmd.2022.07.224 Epub:
Not Epub Abstract:
Myotonic dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy, manifesting in multisystemic effects... Delivery Method:
peptide-linked Organism or Cell Type:
cell culture: patient-derived muytoubes, mice Citation Extract: Grigenrath M, Estrella N, Hicks A, Shen X, Wysk M, Kheirabadi M, Streeter M, Lian W, Liu N, Blake S, Brennan C, Li N, Batagui V, Oye K, Gao N, Wang D, Qian X, Sethuraman N. O.14 EEV-Conjugated PMO results in nuclear foci reduction and aberrant splicing correction in myotonic dystrophy cell and animal models. Neuromuscul Disord. 2022;32(Suppl 1):S96. doi:/10.1016/j.nmd.2022.07.224. |
INTS13 variants causing a recessive developmental ciliopathy disrupt assembly of the Integrator complex
Citation:
Nat Commun. 2022;13(1),6054. doi:10.1038/s41467-022-33547-8 Epub:
Not Epub Abstract:
Oral-facial-digital (OFD) syndromes are a heterogeneous group of congenital disorders characterized by malformations of the... Delivery Method:
microinjection Organism or Cell Type:
Xenopus laevis Citation Extract: Mascibroda LG, Shboul M, Elrod ND, Colleaux L, Hamamy H, Huang K-L, Peart N, Singh MK, Lee H, Merriman B, Jodoin JN, Sitaram P, Lee LA, Fathalla R, Al-Rawashdeh B, Ababneh O, El-Khateeb M, Escande-Beillard N, Nelson SF, Wu Y, Tong L, Kenney LJ, Roy Su, Russell WK, Amiel J, Reversade B, Wagner EJ. INTS13 variants causing a recessive developmental ciliopathy disrupt assembly of the Integrator complex. Nat Commun. 2022;13(1),6054. doi:10.1038/s41467-022-33547-8. |
Trim33 conditions the lifespan of primitive macrophages and onset of definitive macrophage production
Citation:
Development. 2022;149(18):dev200835. doi:10.1242/dev.200835 Epub:
Not Epub Abstract:
Trim33 (Tif1γ) is a transcriptional regulator that is notably involved in several aspects of hematopoiesis. It is essential for... Organism or Cell Type:
zebrafish Citation Extract: Demy DL, Touret A-L, Lancino M, Tauzin M, Capuana L, Pierre C, Herbomel P. Trim33 conditions the lifespan of primitive macrophages and onset of definitive macrophage production. Development. 2022;149(18):dev200835. doi:10.1242/dev.200835. |
N-myc downstream regulated gene 1 (ndrg1) functions as a molecular switch for cellular adaptation to hypoxia
Citation:
eLife. 2022;11:e74031. doi:10.7554/eLife.74031 Epub:
Not Epub Abstract:
Lack of oxygen (hypoxia and anoxia) is detrimental to cell function and survival and underlies many disease conditions. Hence,... Delivery Method:
microinjection Organism or Cell Type:
zebrafish Citation Extract: Park JS. Gabel AM, Kassir P, Kang L, Chowdhary PK, Osei-Ntansah A, Tran ND, Viswanathan S, Canales B, Ding P, Lee Y-S, Brewster R. N-myc downstream regulated gene 1 (ndrg1) functions as a molecular switch for cellular adaptation to hypoxia. eLife. 2022;11:e74031. doi:10.7554/eLife.74031. |
Collective cell migration during optic cup formation features changing cell-matrix interactions linked to matrix topology
Citation:
Curr Biol. 2022;[Epub] doi:10.1016/j.cub.2022.09.034 Epub:
Yes Abstract:
Cell migration is crucial for organismal development and shapes organisms in health and disease. Although a lot of research has... Delivery Method:
microinjection Organism or Cell Type:
zebrafish Citation Extract: Soans KG, Ramos AP, Sidhaye J, Krishna A, Solomatina A, Hoffmann KB, Schlüßler R, Guck J, Sbalzarini IF, Modes CD, Norden C. Collective cell migration during optic cup formation features changing cell-matrix interactions linked to matrix topology. Curr Biol. 2022;[Epub] doi:10.1016/j.cub.2022.09.034. |
Simultaneous imaging of calcium and contraction in the beating heart of zebrafish larvae
Citation:
Theranostics. 2022 Jan 1;12(3):1012-1029. doi: 10.7150/thno.64734. eCollection 2022 Epub:
Not Epub Abstract:
In vivo models of cardiac function maintain the complex relationship of cardiomyocytes with other heart cells, as well as the... Delivery Method:
microinjection Organism or Cell Type:
zebrafish Citation Extract: Salgado-Almario J, Vicente M, Molina Y, Martinez-Sielva A, Vincent P, Domingo B, Llopis J. Simultaneous imaging of calcium and contraction in the beating heart of zebrafish larvae. Theranostics. 2022 Jan 1;12(3):1012-1029. doi: 10.7150/thno.64734. eCollection 2022. |
Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans
Citation:
Sci Adv. 2022 Oct 7;8(40):eabm5859. doi: 10.1126/sciadv.abm5859. Epub 2022 Oct 5 Epub:
Not Epub Abstract:
Molecular responses to influenza A virus (IAV) infections vary between mammalian species. To identify conserved and species-... Delivery Method:
peptide-linked Organism or Cell Type:
mice Citation Extract: Forst CV, Martin-Sancho L, Tripathi S, Wang G, Dos Anjos Borges LG, Wang M, Geber A, Lashua L, Ding T, Zhou X, Carter CE, Metreveli G, Rodriguez-Frandsen A, Urbanowski MD, White KM, Stein DA, Moulton H, Chanda SK, Pache L, Shaw ML, Ross TM, Ghedin E, García-Sastre A, Zhang B. Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans. Sci Adv. 2022 Oct 7;8(40):eabm5859. doi: 10.1126/sciadv.abm5859. Epub 2022 Oct 5. |